QA: Cell Source Inc. in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001569340_2021_Cell_Source_Inc.pdf

Logs

warning Similarly named company. Duplicate? None {'details': [{'other_company': 'International Stem Cell CORP', 'shared_tokens': {'cell'}}]}
warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001569340')"}

Graph

Absolute values for 0001569340, Cell Source Inc.

  xvar xval
0 AssetsCurrent 0
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 452,339
4 LiabilitiesCurrent 8,399,721
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 2,639,482
9 ResearchAndDevelopmentExpense 834,943
10 remainder_Expenses 163,611
11 remainder_Revenues 0
12 remainder_NetIncome -922,129
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 452,339
1 Liabilities 8,399,721
2 Expenses 3,638,036
3 Revenues 0
4 StockholdersEquity -7,947,382
5 NetIncome -4,560,165
6 ComprehensiveNetIncome -4,560,165
7 BaseVar 6,706,112
8 EconomicCapitalRatio -4.12

Edgar->Model Mapping

Feature Distribution

Change over Time